Combined Immunotherapies in Metastatic ER+ Breast Cancer

NCT04563507 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

RADIATION: Stereotactic Body Radiation Therapy (SBRT) (50GY in 5 fractions)
DRUG: Letrozole 2.5Mg Tab
DRUG: Palbociclib 125mg

Sponsor

Weill Medical College of Cornell University